3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
18
Prostatic Neoplasms
16
Colorectal Neoplasms
14
Neoplasms
12
Hematopoietic and Lymphatic System Neoplasm
12
Lung Neoplasms
9
Hematologic Neoplasms
8
Ovarian Neoplasms
5
Multiple Myeloma
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Malignant Solid Neoplasm
4
Lymphoma
4
Urinary Bladder Neoplasms
3
Hematopoietic and Lymphoid System Neoplasm
3
Advanced Malignant Solid Neoplasm
3
Triple Negative Breast Neoplasms
2
Thyroid Cancer, Papillary
2
Pancreatic Neoplasms
2
Oropharyngeal Neoplasms
2
Obesity-Related Malignant Neoplasm
2
Mouth Neoplasms
2
Motor Activity
2
Melanoma
2
Malignant Female Reproductive System Neoplasm
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Laryngeal Neoplasms
2
Hypopharyngeal Neoplasms
2
Head and Neck Neoplasms
2
Genetic Predisposition to Disease
2
Interventions
Gemcitabine
33
Cisplatin
28
pembrolizumab
19
durvalumab
17
Oxaliplatin
16
Fluorouracil
16
Leucovorin
14
Magnetic Resonance Spectroscopy
13
Specimen Handling
9
Biopsy
9
lenvatinib
7
Nivolumab
7
Capecitabine
7
Taxes
6
Paclitaxel
6
Irinotecan
6
fludarabine
5
Folfox protocol
5
Drug Therapy
5
Carboplatin
5
Albumin-Bound Paclitaxel
5
pemigatinib
4
Ipilimumab
4
Fluorodeoxyglucose F18
4
Floxuridine
4
Cyclophosphamide
4
Bevacizumab
4
130-nm albumin-bound paclitaxel
4
tremelimumab
3
olaparib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Cholangiocarcinoma
×
Interviews as Topic
×
1 year
×
Clear all
No trials found.